A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

Inclusion Criteria

• •Confirmed diagnosis of de novo or transformed DLBCL, or follicular grade 3b lymphoma.
• •Received at least four cycles of first-line therapy with R-CHOP, or equivalent.
• •Best clinical response to first-line therapy of stable disease, partial response, or complete response.
• •At least one measureable lesion that is both greater than or equal to 1.5cm by radiographic imaging and by positive FDG-PET scan.